Securing long-term financing =>> Recapitalization of The Vaccine Fund =>>
Long-term GAVI/Vaccine Fund resource mobilization plan (2006 – 2015) fully aligned with long term GAVI strategic planning (2006-2015) and new funding priorities and policies defined for 2006-2015, based on GAVI strategic directions
|Achievement of overall target
|• Cost estimates for options for GAVI phase two investments made based on agreed targets for 2015
• Illustrative ten-year program outlined
• Framework for allocating funds between windows agreed
Responsible entity: The Vaccine Fund
Completed by: December 2005
Total budget: $0
Target description and how it will help reach GAVI milestones
The funding raised by the Vaccine Fund is critical to the success of GAVI. In addition to fueling the purchase of vaccines and immunization services support to governments, these resources create opportunities for innovative new investments to stimulate the availability of needed vaccines in sufficient quantities at a reasonable price. GAVI long-term strategic planning must be informed by the fund raising possibilities of The Vaccine Fund and the alliance, in terms of the nature of activities that will be most attractive to current and prospective donors, the amount of money that can be raised, and the ability of the Vaccine Fund to leverage its balance sheet.
ALL MILESTONES: Alliance fundraising goals will not be met unless VF/GAVI secretariat led fund-raising efforts are closely aligned with the GAVI strategic planning process, recognize the needs of the partners and are based on plans that clearly delineate the roles and responsibilities of each of the partners.
Justification for selection of activities
As GAVI begins its long-term strategic planning process it must consider:
- the estimated costs to meet existing GAVI/VF commitments including analysis of likely uptake
- the estimated costs of achieving the GAVI milestones
- the potential costs of future investments options
- the nature of activities that will be most attractive to current and prospective donors
- amount of funds currently available and the amount of money that can be realistically raised for the Vaccine Fund and alliance partners
The VF resource mobilization plan (including “The Grand Campaign for Childhood Immunization”) will require coordination/integration of the advocacy and fundraising capabilities of the Vaccine Fund and the GAVI Secretariat.
|Coordinating partner/ support partners
|Cost Estimates for Options for Future GAVI/VF Investments
|VF Secretariat WHO UNICEF BMGF
|• Analyses of potential costs of future options for GAVI investments for both VF and partners & realistic assessment of the potential for resource mobilization for each option.
|GAVI Strategic Planning
|Secretariat GAVI EC GAVI Board
|• GAVI strategic plan developed that addresses resource mobilization considerations based on consultation with the partners, particularly VF.
|Vaccine Fund Strategic Planning
|• VF Strategic plan updated to reflect 2006-2015 GAVI strategic plan
|VF Resource Mobilization Planning
|• VF long term resource mobilization plan updated based on GAVI strategic plan and VF strategic plan.
Detailed information on activities
Links to other elements of GAVI work plan are multiple and include procurement and supply of existing products and setting priorities which are particularly important.
Targets by priority area
Securing long-term financing
==>> Financial sustainability
==>> Recapitalization of The Vaccine Fund
• Long-term GAVI/Vaccine Fund resource mobilization plan (2006 – 2015) fully aligned with long term GAVI strategic planning (2006-2015) and new funding priorities and policies defined for 2006-2015, based on GAVI strategic directions
• Vaccine Fund resource mobilization level of $400 million/year achieved by end of 2006 (interim 2005 milestone for this effort is roughly $325 million/yr)
Strategic planning & monitoring
==>> Setting priorities
==>> Monitoring progress
==>> Alliance coordination
Strengthening service delivery
==>> Health information and monitoring systems
==>> Contributing to alleviation of system-wide barriers
==>> Enhanced efforts in large population countries
Ensuring access to vaccines and related products
==>> Procurement/Supply of existing products
==>> Development and introduction of new, near-term products
==>> Managing process for country support from Vaccine Fund